KIAA1143P2

Across TCGA pan-cancer cohorts, KIAA1143P2 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated KIAA1143P2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher KIAA1143P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KIAA1143P2 expression acts as an unfavorable survival marker.

KIRC, ACC, and KICH are the cancer types where KIAA1143P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	III,IV	0.238	0.512	<.001	96	view →
ACC	DFS	Tertile	III,IV	0.051	0.471	<.001	63	view →
KICH	OS	Tertile	All	0.191	0.875	.001	57	view →
OV	OS	Tertile	All	0.543	0.698	.003	48	view →
THCA	DFS	Tertile	All	0.116	0.916	<.001	33	view →
SKCM	DFS	Tertile	All	0.326	0.619	.004	18	view →
LAML	DFS	Tertile	All	0.317	0.487	.023	18	view →
PAAD	OS	Tertile	All	0.204	0.461	.044	9	view →
LIHC	OS	Tertile	All	0.389	0.709	.013	9	view →
LGG	OS	Tertile	All	0.841	0.908	.037	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

KIAA1143P2–KIRC (DFS)

Open the KIRC breakdown →